Potential Utility of Natural Products against Oxidative Stress in Animal Models of Multiple Sclerosis
- PMID: 36009214
- PMCID: PMC9404913
- DOI: 10.3390/antiox11081495
Potential Utility of Natural Products against Oxidative Stress in Animal Models of Multiple Sclerosis
Abstract
Multiple sclerosis (MS) is an autoimmune-mediated degenerative disease of the central nervous system (CNS) characterized by immune cell infiltration, demyelination and axonal injury. Oxidative stress-induced inflammatory response, especially the destructive effect of immune cell-derived free radicals on neurons and oligodendrocytes, is crucial in the onset and progression of MS. Therefore, targeting oxidative stress-related processes may be a promising preventive and therapeutic strategy for MS. Animal models, especially rodent models, can be used to explore the in vivo molecular mechanisms of MS considering their similarity to the pathological processes and clinical signs of MS in humans and the significant oxidative damage observed within their CNS. Consequently, these models have been used widely in pre-clinical studies of oxidative stress in MS. To date, many natural products have been shown to exert antioxidant effects to attenuate the CNS damage in animal models of MS. This review summarized several common rodent models of MS and their association with oxidative stress. In addition, this review provides a comprehensive and concise overview of previously reported natural antioxidant products in inhibiting the progression of MS.
Keywords: animal model; antioxidants; multiple sclerosis; natural products; oxidative stress.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Oxidative stress involvement in the molecular pathogenesis and progression of multiple sclerosis: a literature review.Rev Neurosci. 2024 Jan 2;35(3):355-371. doi: 10.1515/revneuro-2023-0091. Print 2024 Apr 25. Rev Neurosci. 2024. PMID: 38163257 Review.
-
Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.Mol Neurobiol. 2017 Aug;54(6):4723-4737. doi: 10.1007/s12035-016-0014-0. Epub 2016 Jul 22. Mol Neurobiol. 2017. PMID: 27447807
-
Engine Failure in Axo-Myelinic Signaling: A Potential Key Player in the Pathogenesis of Multiple Sclerosis.Front Cell Neurosci. 2021 Feb 10;15:610295. doi: 10.3389/fncel.2021.610295. eCollection 2021. Front Cell Neurosci. 2021. PMID: 33642995 Free PMC article. Review.
-
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.Brain. 2011 Mar;134(Pt 3):678-92. doi: 10.1093/brain/awq386. Brain. 2011. PMID: 21354971
-
Neuronal injury in chronic CNS inflammation.Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):551-62. doi: 10.1016/j.bpa.2010.11.001. Epub 2010 Nov 29. Best Pract Res Clin Anaesthesiol. 2010. PMID: 21619866 Review.
Cited by
-
Role of Medicinal Plants in the Management of Multiple Sclerosis.Curr Pharm Biotechnol. 2025;26(5):665-679. doi: 10.2174/0113892010324850240923181408. Curr Pharm Biotechnol. 2025. PMID: 39390830 Review.
-
Polyphenols in the Central Nervous System: Cellular Effects and Liposomal Delivery Approaches.Int J Mol Sci. 2025 Jul 4;26(13):6477. doi: 10.3390/ijms26136477. Int J Mol Sci. 2025. PMID: 40650253 Free PMC article. Review.
-
Polycaprolactone/graphene oxide/acellular matrix nanofibrous scaffolds with antioxidant and promyelinating features for the treatment of peripheral demyelinating diseases.J Mater Sci Mater Med. 2023 Oct 5;34(10):49. doi: 10.1007/s10856-023-06750-2. J Mater Sci Mater Med. 2023. PMID: 37796399 Free PMC article.
-
Quercetin as a possible complementary therapy in multiple sclerosis: Anti-oxidative, anti-inflammatory and remyelination potential properties.Heliyon. 2023 Oct 29;9(11):e21741. doi: 10.1016/j.heliyon.2023.e21741. eCollection 2023 Nov. Heliyon. 2023. PMID: 37954351 Free PMC article. Review.
-
Effects of Strawberry Tree Water Leaf Extract and Arbutin on Biochemical Markers and DNA Integrity in Brain Cells of Lewis Rats.Toxics. 2024 Aug 16;12(8):595. doi: 10.3390/toxics12080595. Toxics. 2024. PMID: 39195697 Free PMC article.
References
-
- Attfield K.E., Jensen L.T., Kaufmann M., Friese M.A., Fugger L. The immunology of multiple sclerosis. Nat. Rev. Immunol. 2022:1–17. - PubMed
-
- Martin D., Pantoja C., Fernandez M.A., Valdes-Quezada C., Molto E., Matesanz F., Bogdanovic O., de la Calle-Mustienes E., Dominguez O., Taher L., et al. Genome-wide CTCF distribution in vertebrates defines equivalent sites that aid the identification of disease-associated genes. Nat. Struct. Mol. Biol. 2011;18:708–714. doi: 10.1038/nsmb.2059. - DOI - PMC - PubMed
-
- Walton C., King R., Rechtman L., Kaye W., Leray E., Marrie R.A., Robertson N., La Rocca N., Uitdehaag B., van der Mei I., et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult. Scler. 2020;26:1816–1821. doi: 10.1177/1352458520970841. - DOI - PMC - PubMed
-
- Ribbons K.A., Mcelduff P., Boz C., Trojano M., Izquierdo G., Duquette P., Girard M., Grand’Maison F., Hupperts R., Grammond P., et al. Male sex is independently associated with faster disability accumulation in Relapse-Onset MS but not in primary progressive MS. PLoS ONE. 2015;10:e122686 - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources